Avant Diagnostics, Inc (OREO) [Rocket]

In millions, except per share items	Sep-30-18	Sep-30-17	Sep-30-16	Sep-30-15	Oct-31-14	Sep-30-14	Oct-31-13	Oct-31-12
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.3	0.1	2.0	0.0	0.0	0.0	-1.4
Revenue growth	-100.0%	116.8%	-94.1%				-100.0%
Cost of goods sold	0.0	0.0	0.1	-0.7	0.0	0.0	0.0	0.0
Gross profit	0.0	0.2	0.1	2.7	0.0	0.0	0.0	-1.4
Gross margin		89.2%	55.5%	135.1%				100.0%
Selling, general and administrative [+]	2.3	8.6	1.5	0.7	0.0	0.5	0.3	0.6
Sales and marketing	1.4	2.6	1.2	0.6
General and administrative [+]	0.9	6.0	0.3	0.1	0.0		0.3	0.6
General and administrative expenses					0.0	452.3	0.3	0.6
Professional fees	0.9	6.0	0.3	0.1		0.1
Rent expense						0.0
Other selling, general and administrative	1.4	2.6	1.2	0.6
Research and development				0.0
Other operating expenses	0.0			1.3		-0.5
EBITDA [+]	-1.8	-7.9	-1.1
EBITDA growth	-76.5%	591.7%	-273.3%		-89.1%		-84.3%	396.7%
EBITDA margin		-3077.2%	-964.7%	32.8%				141.6%
Depreciation and amortization	0.5	0.4	0.3
EBIT [+]	-2.3	-8.3	-1.5	0.7	0.0	0.0	-0.3	-2.0
EBIT growth	-72.2%	462.9%	-325.1%		-89.1%		-84.3%	396.7%
EBIT margin		-3252.1%	-1252.8%	32.8%				141.6%
Non-recurring items [+]			10.1	2.0
Asset impairment				2.0
In-process research & development			10.1
Interest expense, net [+]	0.0	0.0	0.1
Interest expense	0.0		0.1
Interest income		0.0
Other income (expense), net [+]	0.0	-1.3	-0.1	-2.0		0.5		2.0
Gain (loss) on investments	0.0
Unrealized gain/loss on derivatives	0.1	0.0	0.0
Other non-operating income	0.1	0.1
Other non-ooperating expenses	0.1	1.4	-0.2
Other	0.2	1.5	0.2	2.0
Pre-tax income	-2.4	-9.6	-11.8	-3.3	0.0	0.5	-0.3	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	200.0%	0.0%
Net income	-2.4	-9.6	-11.8	-3.3	0.0	-0.5	-0.3	-2.0
Net margin		-3745.2%	-9961.9%	-167.2%				141.6%

Basic EPS [+]	($0.01)	($0.05)	($0.08)	($0.04)	$0.00	($0.01)	$0.00	($0.02)
Growth	-79.4%	-40.5%	106.5%	272.2%	-89.1%		-84.6%	358.7%
Diluted EPS [+]	($0.01)	($0.05)	($0.08)	($0.04)	$0.00	($0.01)	$0.00	($0.02)
Growth	-79.4%	-40.5%	106.5%	272.2%	-89.1%		-84.6%	358.7%

Shares outstanding (basic) [+]	240.7	200.2	146.2	85.8	107.4	50.2	107.1	105.5
Growth	20.2%	36.9%	70.3%	71.1%	0.2%		1.5%	5.8%
Shares outstanding (diluted) [+]	240.7	200.2	146.2	85.8	107.4	50.2	107.1	105.5
Growth	20.2%	36.9%	70.3%	71.1%	0.2%		1.5%	5.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.